USSTOCK.TODAY
Market Closed Log in Sign up

Biolife Solutions Inc(BLFS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

Halted
Trading Halted Since 2026-10-26: Trading has been halted. It may resume, and prices shown reflect the last trading day.
BLFS
BLFS
Halted
Biolife Solutions Inc
At close Oct 5 at 4:00 PM ET (Korea 10/6 05:00)
$38.61
+0.00 +0.00%
Wedge Up Resistance 40.41 Support 38.97 Broke below support

AI-drawn chart patterns are for reference only.

Full metrics table

Index ⓘ -P/E ⓘ 39.93EPS (ttm) ⓘ 0.97Insider Own ⓘ 0.44%Shs Outstand ⓘ 48.9MPerf Week ⓘ -
Market Cap ⓘ 1.89BForward P/E ⓘ 133.14EPS next Y ⓘ -43.14%Insider Trans ⓘ -84.79%Shs Float ⓘ 48.7MPerf Month ⓘ 4.78%
Enterprise Value ⓘ 1.82BPEG ⓘ -EPS next Q ⓘ 0.05Inst Own ⓘ 100.59%Short Float ⓘ 8.21%Perf Quarter ⓘ 32.73%
Income ⓘ 0.05BP/S ⓘ 18.37EPS this Y ⓘ 304%Inst Trans ⓘ -Short Ratio ⓘ 3.56Perf Half Y ⓘ 79.58%
Sales ⓘ 0.10BP/B ⓘ 4.49EPS next 5Y ⓘ -ROA ⓘ 12.09%Short Interest ⓘ 4.00MPerf YTD ⓘ 59.68%
Book/sh ⓘ 8.59P/C ⓘ 22.92EPS past 3/5Y ⓘ 54.38% -55.02%ROE ⓘ 13.15%52W High ⓘ -2.89% ($39.76)Perf Year ⓘ 45.2%
Cash/sh ⓘ 1.68P/FCF ⓘ 232.9Sales past 3/5Y ⓘ -15.9% 14.88%ROIC ⓘ 11%52W Low ⓘ 116.18% ($17.86)Perf 3Y ⓘ 191.18%
Dividend Est. ⓘ -EV/EBITDA ⓘ 284.26EPS Y/Y TTM ⓘ 981.57%Gross Margin ⓘ 64.76%Volatility(W/M) ⓘ 3.59% 2.78%Perf 5Y ⓘ -3.81%
Dividend TTM ⓘ -EV/Sales ⓘ 17.72Sales Y/Y TTM ⓘ 0.17%Oper. Margin ⓘ 2.9%ATR (14) ⓘ 1.13Perf 10Y ⓘ 2106.29%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 7.14EPS Q/Q ⓘ 376.1%Profit Margin ⓘ 46.35%RSI (14) ⓘ 60.55Recom ⓘ 3
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 9.69Sales Q/Q ⓘ 11.98%SMA20 ⓘ 4.12% ($37.08)Beta ⓘ 1.75Target Price ⓘ $30.8
Payout ⓘ -Debt/Eq ⓘ 0.04Earnings ⓘ 2026/8/6SMA50 ⓘ 8.17% ($35.69)Rel Volume ⓘ 0Prev Close ⓘ $38.61
Employees ⓘ 155LT Debt/Eq ⓘ 0.03EPS/Sales Surpr. ⓘ 2807.35% 2.41%SMA200 ⓘ 45.03% ($26.62)Avg Volume(3M) ⓘ 1.12MPrice ⓘ $38.61
IPO ⓘ 1989/11/22Option/Short ⓘ No/NoTrades ⓘ 0Volume ⓘ -Change ⓘ -
Company
BLFS BLFSBiolife Solutions Inc | NASD | Medical Instruments & Supplies Deep dive

🧬 BioLife Solutions (BLFS) is a U.S. healthcare company that develops, manufactures, and sells bioprocessing tools and services for the cell and gene therapy industry. Centered on its core biopreservation (cryopreservation) media products, the company combines controlled-rate freezing and thawing systems with storage services to provide an infrastructure that supports the entire production, shipping, and storage process for cell therapies.

Quote

Over the past 1 year, on the higher side

3% below its 1-year high.

Now $38.61
52w low$17.8652w high$39.76
52W Range95%
Volume ⓘ 0

Traded less than usual. That is 0% of its average volume.

B
Overall · fairly good
We judged 7 of the 8 questions below. 4 rate excellent and 3 need caution.
Not applicable: dividends.
ETFs holding this stock 5 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Medical Instruments & Supplies

It ranks #24 of 53 in the industry

Based on market cap of $2B.

FAQ

FAQ

BLFS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

The market cap of BLFS is approximately $1.9B, ranking 2,081 within its sector.

BLFS has a P/E ratio of approximately 39.9x, which can be used to assess its valuation relative to the Healthcare sector average.

BLFS has recorded a 52-week high of $39.76 and a low of $17.86.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels